ArticleCancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology2026
Multiple Primary Cancer Incidence by County-Level Smoking Prevalence among U.S. Cancer Survivors.
Article in Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Pan-cancer analysis identifies KANSL2 as a cell-cycle-associated regulator of tumor progression and immunity in liver hepatocellular carcinoma.Clinical and experimental medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundAs the number of cancer survivors in the United States grows, multiple primary cancer (MPC) has become an increasing public health concern. Understanding geographic variation in MPC incidence can inform targeted public health strategies. In this study, we aimed to examine associations between MPC incidence and county-level cigarette smoking (smoking) prevalence.
methodsWe conducted a retrospective cohort study using data from the Surveillance, Epidemiology, and End Results 17 registries, representing 26.5% of the U.S. population. The cohort included 6,364,027 individuals diagnosed with an initial primary cancer between 2000 and 2021, followed through December 2021. County-level smoking prevalence was the primary exposure. The main outcome was MPC incidence, assessed using observed-to-expected ratios across strata of smoking prevalence. Analyses were stratified by sex, age, and race/ethnicity.
resultsObserved-to-expected ratios of MPC increased with higher county-level smoking prevalence, from 1.02 (95% CI, 1.01-1.03) among males and 1.24 (95% CI, 1.22-1.25) in females in low-prevalence counties to 1.34 (95% CI, 1.31-1.38) and 1.53 (95% CI, 1.49-1.58), respectively, in high-prevalence counties. Robust relationships were observed among individuals diagnosed with their initial cancer at ages 45 to 64.
conclusionCounty-level smoking prevalence is positively associated with MPC incidence. These findings support the need for targeted, community-level tobacco control interventions to reduce MPC risk. IMPACT: By linking county-level smoking prevalence to MPC risk, this study highlights the potential utility of community-level data in identifying high-risk populations and guiding tobacco control and survivorship interventions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.